News in brief: Third time lucky for Grifols

The Spanish bio-pharmaceuticals group Grifols, which has tried to float twice before, launched its €960m ($1.2bn) initial public offering last week. It is set to be Spain's largest IPO since the €1.3bn float of Cintra, the Spanish toll road operator, in 2004. Grifols could raise up to €320m from selling 71 million new shares at €4 to €4.50 each. Morgan Stanley is leading the deal.

Goldman frozen out

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump